International consensus guidelines on anticardiolipin and anti–β2‐glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies
- 29 December 2011
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 64 (1), 1-10
- https://doi.org/10.1002/art.33349
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Traceability in Laboratory MedicineClinical Chemistry, 2009
- Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classificationJournal of Thrombosis and Haemostasis, 2008
- A Quarter of a Century in Anticardiolipin Antibody Testing and Attempted Standardization Has Led Us to Here, which Is?Seminars in Thrombosis and Hemostasis, 2008
- Appropriate calibration curve fitting in ligand binding assaysThe AAPS Journal, 2007
- Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndromeClinical Rheumatology, 2006
- Development of Consensus Guidelines for Anticardiolipin and Lupus Anticoagulant TestingSeminars in Thrombosis and Hemostasis, 2005
- Assessing the variation in antiphospholipid antibody (APA) assays: comparison of results from 10 centersAmerican Journal of Obstetrics and Gynecology, 2004
- Consensus guidelines on anti-cardiolipin antibody testing and reportingPathology, 2004
- A chimeric antibody with the human ?1 constant region as a putative standard for assays to detect IgG ?2-glycoprotein I-dependent anticardiolipin and anti-?2-glycoprotein I antibodiesArthritis & Rheumatism, 1999
- IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and DeathStroke, 1997